genesis plenary session by HC120911195715

VIEWS: 1 PAGES: 2

									Genesis Plenary Session

10.50 – 11.30 Tea/Coffee, networking and exhibitor visits

11.30 – 13.00 Genesis Sessions: “Bioengineering in Medicine” & “Imaging in Drug Discovery”

13.00 – 14.15 Lunch, networking and exhibitor visits

14.15 – 15.45 Genesis Sessions: “Nurturing Innovative Medical Technology” & Current pe-clinical
strategies”

15.45 – 16.30 Tea/Coffee, networking and exhibitor visits

16.30 – 18.00 Genesis Conference sessions: Latest approaches to clinical trial design” & “Next wave
technologies in drug discovery”

18.00 – Drinks reception followed by the UKTI Genesis Awards Dinner

Friday 11th December 2009

08.50   Welcome from the Chair, David Parry, CEO SEHTA

09.00 – 10.00 Session 1 – Setting off

09.00   The structure of the medical technology sector in the UK

         Barnaby Perks, ERBI

09.20   Evaluating the market potential of your product

         MATCH Speaker tbc

09.40   Developing the value proposition for investors

         Stuart Hendry, Sphere Medical

10.00 – 10.30 – Coffee

10.30   – 11.30 Session 2 – Are we there yet?

10.30   Comparing the FDA and EMEA approaches to approval for biomarkers

         Patricia Hurley, Head of Biomarkers Division, ERA Consulting

10.50   Undertaking med tech clinical trials in the NHS

         Prof. Gordon Ferns, Dean of Medicine, University of Surrey

11.10   Preparing to market your product

         Bill Dolphin, Avita Medical

11.30 – 12.15 – Coffee and refreshment

12.00 – 13.15 – Session 3 – We’ve arrived!

12.00   Building revenues through entering the US market

         Ted Agne, Communications Strategy Group
12.20   Keynote Debate:

        The OLS Blueprint has the NHS as an Innovation Champion, but how can you get your
        innovative med tech product adopted by the NHS?

        Chair: Bill Dawson

        Panellists:

        Prof Gordon Ferns, University of Surrey

        Mark McIntyre, Boston Scientific

        Others to be confirmed

13.15   Conference close

								
To top